Molecule Graphic

BioPharma in Ohio III:

Fighting Chronic Disease with

Innovation & Products from Ohio

Event Info

Thank You

Thanks to our speakers, panelists, partner organizations and the attendees for making the 2008 Ohio Biz/Bio Event a success!

BioPharma in Ohio III:

Fighting Chronic Disease with Innovation & Products from Ohio

May 7, 2008

12:00 p.m. – 4:30 p.m.

The Westin Columbus

Agenda

Below is the most recent agenda of the day’s events. Due to the busy schedules of several speakers, panelist and participants, the agenda is subject to revision.

11:30 AM	Registration Open
12:00 PM	Luncheon with Keynote Address Kenneth Thorpe, Ph.D. Executive Director Partnership to Fight Chronic Disease (confirmed)
1:15 PM	Transition Break
1:30 PM	Panel One: Ohio Innovation: Moving Chronic Disease Research to Commercialization Moderator: Marsha Wills-Karp, Ph.D. Professor of Pediatrics & Director of Immunobiology University of Cincinnati Department of Pediatrics (confirmed) John Kopchick, Ph.D. Goll-Ohio Eminent Scholar & Professor Edison Biotechnology Institute & Dept. of Biomedical Sciences Ohio University (confirmed) David D'Alessio, M.D. Professor of Medicine Albert Vontz Chair for Diabetes Research Department of Internal Medicine University of Cincinnati (confirmed) Clay B. Marsh, M.D. Professor of Medicine, College of Medicine Director, Center for Critical Care & Sleep Medicine Vice Chair, Research, Department of Internal Medicine Ohio State University (confirmed) Roy L. Silverstein, M.D. Chairman, Department of Cell Biology Vice Chair for Translational Research, Lerner Research Institute, Cleveland Clinic Professor of Molecular Medicine, Case School of Medicine (confirmed) Representatives from Ohio’s world class research institutions will discuss the current development of treatments and devices that address chronic conditions such as obesity, diabetes, heart and pulmonary disorders.
2:40 PM	Panel Two: Ohio Industry & Commerce: Fighting Chronic Disease and Realizing Business Opportunities Moderator: Anthony J. Dennis, Ph.D. President & CEO BioOhio (confirmed) Tom Ludlam Chief Executive Officer Prologue Research, Inc. (confirmed) Andreas Grauer, M.D. Global Executive Medical Director New Technology Development Procter & Gamble Pharmaceuticals (confirmed) Diana Reed Senior Public Affairs Executive Amylin Pharmaceuticals, Inc. (confirmed) Mark Low, B.A., M.S. Managing Director Global Cardiovascular Innovation Center (confirmed) Representatives on panel two will come from Ohio companies and institutions that are experiencing the business advantage of chronic disease treatment and management.
3:45 PM	Closing Remarks Lee Fisher Lieutenant Governor Office of the Governor of Ohio (confirmed)
4:00 PM	Networking, Coffee & Dessert Reception

Squares Graphic